Delphinus Medical Technologies

Novi, MI · Founded 2010 · Privately Held (backing)

Developer of an ultrasound system designed to transform the early detection of breast cancer. Delphinus Medical Technologies is based in Novi, MI and was founded in 2010. It was valued at $210 million at its later-stage round in Aug 2023, the last priced event on record. It has raised $161 million across 5 recorded rounds; the latest was a $27.6 million debt round in Mar 2024.

PMV mark · valuation
$210.0M
Oct 2026
Priced at
its later-stage round
Aug 2023
Total raised
$161.4M
Last round
Debt
Mar 2024
What is Delphinus Medical Technologies worth?
$210.0MPrivateMarketView mark · Oct 2026

Valued at $210.0M at its later-stage round, Aug 2023. Nothing has traded since.

Free account
More of Delphinus Medical Technologies with a free account
  • ·The complete investor list: 14 names
  • ·Watch Delphinus Medical Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Delphinus Medical Technologies funding history

5 rounds
DateRoundRaisedPost-money
Mar 2024Debt$27.6M▮
Jun 2023Early Stage VC$5.0M▮
Aug 2022Early Stage VC$30.4M▮
Apr 2017Early Stage VC$8.2M▮
Aug 2015Early Stage VC$39.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Delphinus Medical Technologies valuation

Delphinus Medical Technologies was valued at $210 million at its later-stage round in Aug 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Delphinus Medical Technologies raised?

Delphinus Medical Technologies has raised $161 million across 5 recorded rounds since 2015. The largest was an $8.2 million early-stage round in Apr 2017; the most recent was a $27.6 million debt round in Mar 2024.

Delphinus Medical Technologies has filed 9 Form Ds with the SEC since 2010, most recently in Apr 2025 ($27.6 million sold to 8 investors).

How Delphinus Medical Technologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Delphinus Medical Technologies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Delphinus Medical Technologies

What is Delphinus Medical Technologies worth?
Delphinus Medical Technologies is valued at $210.0M as of Oct 2026. Valued at $210.0M at its later-stage round, Aug 2023. Nothing has traded since.
How much has Delphinus Medical Technologies raised?
Delphinus Medical Technologies has raised $161.4M in total funding across 5 recorded rounds.
When did Delphinus Medical Technologies last raise?
Delphinus Medical Technologies last raised in Mar 2024 (Debt), raising $27.6M.